Final results of urelumab, an anti-CD137 agonist monoclonal antibody, in combination with cetuximab or nivolumab in patients with advanced solid tumors.
Nikhil I KhushalaniPatrick A OttMatthew J FerrisTina CasconeDirk SchadendorfDung T LeManish R SharmaFabrice BarlesiWilliam SharfmanJason John LukeIgnacio Melero BermejoDeanne LathersJaclyn NeelySatyendra SuryawanshiAbanti SanyalJames L HollowayRasika SuryawanshiScott ElyNeil H SegalPublished in: Journal for immunotherapy of cancer (2024)
NCT02110082; NCT02253992.